Parse Biosciences launches a fully integrated immune repertoire and whole transcriptome analysis workflow in its data analysis platform, Trailmaker.

Melanoma, known for its aggressiveness and high mutational burden, presents itself as a prime candidate for neoantigen-targeted immunotherapies. Although ...

Special Olympics has issued a powerful global call to action, warning that the world is facing a critical shortage of ...

According to Nova One Advisor, the global next-generation sequencing market size is calculated at USD 17.37 billion in 2026 ...

Superior HealthPlan ("Superior"), a leading managed care organization in Texas and a Centene company , has designated ...

Scientists can peer into cells to get a limited view of their activity using microscopes and other tools. However, cells and ...

Transcriptome-based NGS outperforms traditional viral testing with superior sensitivity, detecting viruses including novel ...

Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have found that a key ...

Parse Biosciences & Graph Therapeutics partner to build large functional immune perturbation atlas: Seattle Thursday, January 22, 2026, 11:00 Hrs [IST] Parse Biosciences, a global ...

The NCCN guidelines now include MammaPrint for identifying HR+/HER2- early-stage breast cancer patients who may benefit from ...

Pediatric acute myeloid leukemia (AML) is one of the most common acute leukemias in children. While treatment outcomes have ...

New findings offer insight into why some embryos fail to develop past zygotic genome activation (ZGA), pointing to an unexpected root of human ...